<?xml version="1.0" encoding="UTF-8"?>
<p>Following digital triage, patients could benefit from an at-home diagnostic service. Similar to over-the-counter genetic or urinary tract infection tests, patients could receive a test kit via mail. The use of a drone delivery method could also be considered as a potential and efficient solution to ensure both a timely diagnosis and patient confidentiality. Some test kits may require laboratory analysis [
 <xref rid="B26-ijerph-17-02906" ref-type="bibr">26</xref>,
 <xref rid="B27-ijerph-17-02906" ref-type="bibr">27</xref>], while other tests could utilize a smartphone to assist in the interpretation of test results [
 <xref rid="B28-ijerph-17-02906" ref-type="bibr">28</xref>]. If results are positive, patients could receive a virtual consultation to explain the next steps. Additionally, all positive results should be communicated and reported to the appropriate agency. At-home diagnostic test kits seem promising and have the potential to reduce the pressure on the healthcare system. However, the United States Food and Drug Administration stated that as of 20 March 2020, there had been no authorization for the use of an at-home diagnostic tool for COVID-19 [
 <xref rid="B29-ijerph-17-02906" ref-type="bibr">29</xref>].
</p>
